NFKB1 and type 2 diabetes mellitus: Additionally, we found that ucOCN partially suppresses ER stress and improves insulin signal transduction via PI3K/Akt/NF-κB signaling in HUVECs, implicating ucOCN as a novel therapeutic target for the treatment of the vascular complications of T2DM.